Alain C Borczuk
Overview
Explore the profile of Alain C Borczuk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
127
Citations
5232
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Borczuk A
Surg Pathol Clin
. 2024 May;
17(2):307-320.
PMID: 38692813
Adoption of molecular testing in lung cancer is increasing. Molecular testing for staging and prediction of response for targeted therapy remain the main indications, and although utilization of blood-based testing...
3.
Borczuk A
Surg Pathol Clin
. 2024 May;
17(2):203-214.
PMID: 38692805
The pathology of severe COVID-19 lung injury is predominantly diffuse alveolar damage, with other reported patterns including acute fibrinous organizing pneumonia, organizing pneumonia, and bronchiolitis. Lung injury was caused by...
4.
5.
Altorki N, Bhinder B, Borczuk A, Elemento O, Mittal V, McGraw T
Cell Rep Med
. 2024 Feb;
5(3):101438.
PMID: 38401548
In early-stage non-small cell lung cancer, the combination of neoadjuvant anti-PD-L1 and subablative stereotactic body radiation therapy (SBRT) is associated with higher rates of major pathologic response compared to anti-PD-L1...
6.
Altorki N, Walsh Z, Melms J, Port J, Lee B, Nasar A, et al.
Nat Commun
. 2024 Jan;
15(1):225.
PMID: 38172131
No abstract available.
7.
Altorki N, Walsh Z, Melms J, Port J, Lee B, Nasar A, et al.
Nat Commun
. 2023 Dec;
14(1):8435.
PMID: 38114518
We previously reported the results of a randomized phase II trial (NCT02904954) in patients with early-stage non-small cell lung cancer (NSCLC) who were treated with either two preoperative cycles of...
8.
Borczuk A
Mod Pathol
. 2023 Nov;
37(2):100378.
PMID: 37931841
COVID-19 is characterized by an acute respiratory illness that, in some patients, progresses to respiratory failure, largely demonstrating a pattern of acute respiratory distress syndrome. Excluding fatal cases, the outcome...
9.
Cheong J, Ravishankar A, Sharma S, Parkhurst C, Grassmann S, Wingert C, et al.
Cell
. 2023 Aug;
186(18):3882-3902.e24.
PMID: 37597510
Inflammation can trigger lasting phenotypes in immune and non-immune cells. Whether and how human infections and associated inflammation can form innate immune memory in hematopoietic stem and progenitor cells (HSPC)...
10.
Savage A, Risquez C, Gomi K, Schreiner R, Borczuk A, Worgall S, et al.
Front Med (Lausanne)
. 2023 Mar;
10:1139397.
PMID: 36910476
Introduction: In addition to the traditional activation of resident receptors by release of local mediators, new evidence favors the existence of exosomes in cell-to-cell communication that mediates delivery of specific...